Alzmenda 5 mg tablets

It works as a non-competitive NMDA receptor antagonist.

Composition:

• Each tablet contains memantine hydrochloride 5 mg.
• Excipients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, macrogol, titanium dioxide.

Properties:

A remedy for dementia. Memantine is a non-competitive antagonist of glutamate NMDA receptors, including in the substantia nigra. It reduces the excessive stimulating effect of cortical glutamate neurons on the neostriatum, which develops with insufficient dopamine release. By reducing Ca2+ entry into neurons, it lowers the risk of their destruction.

• It has nootropic, cerebrovasodilating, antihypoxic and psychostimulating effects.
• It improves weakened memory, increases the ability to concentrate, reduces fatigue and depression symptoms, and reduces skeletal muscle spasticity caused by diseases or brain damage.

Indications:

• Moderate to severe dementia in Alzheimer's disease.

Storage:

Store at a temperature not higher than 30 °C.

Packaging:

• Pack of 14 film-coated tablets (drug list pack: 14).
• The cardboard box contains 1, 2, 3 or 4 blisters of 7 tablets each, with a paper leaflet.